Bevespi Aerosphere Prices, Coupons and Patient Assistance Programs
Bevespi Aerosphere (formoterol/glycopyrrolate) is a member of the bronchodilator combinations drug class and is commonly used for COPD, and COPD - Maintenance.
Bevespi Aerosphere Prices
The cost for Bevespi Aerosphere inhalation aerosol (4.8 mcg-9 mcg/inh) is around $239 for a supply of 5.9 grams, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Bevespi Aerosphere is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Bevespi Aerosphere availability.
This Bevespi Aerosphere price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Inhalation Aerosol
Quantity | Per unit | Price |
---|---|---|
5.9 grams | $40.49 | $238.91 |
10.7 grams | $40.94 | $438.04 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Bevespi Aerosphere Coupons and Rebates
Bevespi Aerosphere offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Bevespi Aerosphere Savings Program: Eligible commercially insured patients may pay $0 per prescription; maximum savings limit of $100 per 30-day supply (1 inhaler); for additional information contact the program at 877-469-1844.
- Applies to:
- Bevespi Aerosphere
- Number of uses:
- Per prescription until program expires
Form more information phone: 877-469-1844 or Visit website
Bevespi Aerosphere Savings Program: Eligible cash-paying & commercially insured/RX not covered patients may save up to $100 per 30-day supply (1 inhaler); for additional information contact the program at 877-469-1844.
- Applies to:
- Bevespi Aerosphere
- Number of uses:
- Per prescription until program expires
Form more information phone: 877-469-1844 or Visit website
Patient Assistance Programs for Bevespi Aerosphere
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: AZ&Me Prescription Savings Program for people without insurance
Elligibility requirements:- Must have no prescription coverage for needed medication
- Varies
- Not required
- The patient must also be a US resident.
- People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.
- Bevespi Aerosphere (glycopyrrolate-formoterol fumarate) Aerosol; Inhalation
More information please phone: 800-292-6363 Visit Website
Provider: AZ&Me Prescription Savings Program for people with Medicare Part D
Elligibility requirements:- Contact program for details.
- Varies
- Not required
- The patient must also be a US resident.
- Eligibility determined on a case-by-case basis.
- Bevespi Aerosphere (glycopyrrolate-formoterol fumarate) Aerosol; Inhalation
More information please phone: 800-292-6363 Visit Website
More about Bevespi Aerosphere (formoterol / glycopyrrolate)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (7)
- En español
- Drug class: bronchodilator combinations
- FDA approval history